Want to join the conversation?
$LIFE appointed David King as SVP, Research. King will lead $LIFE's research and preclinical efforts to advance its Physiocrine biology and support clinical development of meaningful medicines. $LIFE granted King an option to buy 145,000 common shares with exercise price of $3.29 per share.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?